source
- Roche prepares launch of breast cancer pill giredestrant amid patient anticipationRoche is gearing up for the launch of its new oral breast cancer therapy, giredestrant. Teresa Graham, head of Roche's pharma unit, said patients are anxiously awaiting the drug. The announcement…
- Regulatory update: Hepatitis B hold lifted for Arbutus drug and Ultomiris receives accelerated approvalA regulatory update notes that the FDA has removed the clinical hold on Arbutus Biopharma's hepatitis B candidate, clearing the path for the company to resume development after a prolonged review.…